首页> 外国专利> New acyclic or cyclic organophosphorus compounds, are gamma-delta-T cell activators useful e.g. as medicaments for treating asthma, chronic bronchitis, ulcerative colitis, autoimmune diseases or allergies

New acyclic or cyclic organophosphorus compounds, are gamma-delta-T cell activators useful e.g. as medicaments for treating asthma, chronic bronchitis, ulcerative colitis, autoimmune diseases or allergies

机译:新的无环或环状有机磷化合物是可用的γ-δ-T细胞活化剂。作为治疗哮喘,慢性支气管炎,溃疡性结肠炎,自身免疫性疾病或过敏的药物

摘要

Organophosphorus compounds (I), including acyclic and cyclic phosphates, pyrophosphates, triphosphates, phosphonates and phosphinates, are new. Organophosphorus compounds of formula (I) are new. R1 = Me, CHO, optionally substituted hydroxymethyl or CH2R31; R31 = OH, optionally substituted phosphate or optionally substituted pyrophosphate; R33 = H, optionally substituted phosphate or optionally substituted pyrophosphate; R3 = H, optionally substituted 1-26C alkyl, optionally substituted 1-26C hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted 2-26C alkenyl, optionally substituted 2-26C alkynyl, optionally substituted cycloalkyl, optionally substituted heterocyclyl, optionally substituted phosphate, silyl, nucleoside, nucleoside mon-, di- or triphosphate, deoxynucleotide, cation of an (in)organic base (especially a Group I-III non-transition metal, optionally substituted ammonium, ethylene diamine-derived or aminoacid-derived cation) or OR34; R34 = as R3; X1 = O or -C(Y1)(Y2)-; X2 = OR6, -X3-P(O)(OR7)(OR8), -Z1-P(O)(OR4)-X3 or a group as defined for X1 or forming a ring with C1; X3 = -Z2-P(O)(OR5)-X4 or a group as defined for X1 or forming a ring with C1; R4, R5 = as R3; R7, R8 = as R34; Z1, Z2 and X4 (forming a ring with C1) = as X1; R2 = H, OH, alkoxy, phenoxy, benzyloxy, optionally substituted phosphate or optionally substituted pyrophosphate; X2 = O or -C(Y1)(Y2)-; and Y1, Y2 = H, OH, halo, NH2, 1-9C alkoxy or 1-9C alkylthio; or together form =O. Provided that: (1) a double bond is optionally presence between C1 and C2 or C2 and C3; and (2) R31 and R3 are not simultaneously present in the molecule. AN Independent claim is included for the preparation of (I).
机译:新的有机磷化合物(I),包括无环和环状的磷酸盐,焦磷酸盐,三磷酸盐,膦酸盐和次膦酸盐。式(I)的有机磷化合物是新的。 R1 = Me,CHO,任选取代的羟甲基或CH2R31; R 31 = OH,任选取代的磷酸盐或任选取代的焦磷酸盐; R 33 = H,任选取代的磷酸盐或任选取代的焦磷酸盐; R 3 = H,任选取代的1-26C烷基,任选取代的1-26C羟烷基,任选取代的芳基,任选取代的芳烷基,任选取代的2-26C烯基,任选取代的2-26C炔基,任选取代的环烷基,任选取代的杂环基,任选取代磷酸,甲硅烷基,核苷,核苷单,二或三磷酸,脱氧核苷酸,有机碱(特别是I-III组非过渡金属)的阳离子,特别是取代的铵,乙二胺或氨基酸衍生的阳离子)或OR34; R34 =与R3相同; X1 = O或-C(Y1)(Y2)-; X2 = OR6,-X3-P(O)(OR7)(OR8),-Z1-P(O)(OR4)-X3或X1定义的基团或与C1形成环; X3 = -Z2-P(O)(OR5)-X4或X1所定义的基团或与C1形成环; R4,R5 =作为R3; R7,R8 =与R34相同; Z1,Z2和X4(与C1形成环)= X1; R 2 = H,OH,烷氧基,苯氧基,苄氧基,任选取代的磷酸盐或任选取代的焦磷酸盐; X2 = O或-C(Y1)(Y2)-; Y1,Y2 = H,OH,卤素,NH2、1-9C烷氧基或1-9C烷硫基;或一起形成= O。前提是:(1)C1和C2或C2和C3之间任选存在双键; (2)R31和R3不能同时存在于分子中。准备(I)包括独立索赔。

著录项

  • 公开/公告号DE10135395A1

    专利类型

  • 公开/公告日2003-02-13

    原文格式PDF

  • 申请/专利权人 JOMAA PHARMAKA GMBH;

    申请/专利号DE2001135395

  • 申请日2001-07-25

  • 分类号C07F9/09;C07F9/6568;C07F9/547;C12Q1/25;C07F9/113;C12N9/99;A61K31/66;C07F9/6574;

  • 国家 DE

  • 入库时间 2022-08-21 23:42:53

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号